JMC DOES NOT USE METHYLPREDNISOLONE ACETATE

October 8, 2012

On September 26, 2012, the Food and Drug Administration (FDA) recalled three lots of New England Compounding Center (NECC) Methylprednisolone Acetate which have been associated with Aspergillus meningitis following epidural back injections. Jupiter Medical Center was not a facility listed in this recall, and we never had these three lot numbers at our facility. 

As a result of a recent FDA advisory, and out of an abundance of caution, an expanded voluntary recall of all NECC products was officially announced on October 6, 2012. 

At Jupiter Medical Center, we care about the health and wellness of our patients. We are following the FDA advisory to notify all patients who have received any medications from the NECC beginning May 21, 2012 to date. The Centers for Disease Control and Prevention (CDC) does not have firm evidence that fungal infections have been caused by exposure to other NECC products. 

Again, there have been no reported infections from any other NECC medications. This notification is just precautionary. For questions or concerns, please call your physician, or Jupiter Medical Center at (561) 263-4455. 

For more information on the outbreak, call the FDA’s Division of Drug Information at (855) 543-DRUG (3784) and press * or visit the CDC’s website at http://www.cdc.gov/HAI/outbreaks/meningitis.html.

Jupiter Medical Center does not have - nor has ever had - any products from Ameridose.

 

PR 2012